Medicine and Dentistry
Electronic Health Record
100%
Mental Disorder
85%
Systematic Review
82%
Language Processing
73%
Meta-Analysis
51%
Cohort Analysis
48%
Prodrome
43%
Cannabidiol
43%
Precision Psychiatry
43%
Umbrella Review
34%
Mood Disorder
32%
Dronabinol
28%
Volunteer
28%
Cannabis
28%
Attentional Bias
28%
Mental Health
28%
Schizophrenia Spectrum Disorder
20%
Diseases
19%
Mental Health Care
18%
Electroencephalogram
14%
Physical Disease
14%
Catatonia
14%
Diagnostic Accuracy
14%
COVID-19
14%
Randomized Clinical Trial
14%
Biological Marker
14%
Benzodiazepine
14%
Antipsychotic
14%
Adverse Effect
14%
Personalized Medicine
14%
Local Adaptation
14%
Cannabis Use
14%
Proportional Hazards Model
13%
National Health Service
12%
Depressive Disorder
12%
Psychiatry
12%
Positive and Negative Syndrome Scale
9%
All Cause Mortality
9%
Adverse Event
9%
Biomedical Research
8%
Sensitivity and Specificity
8%
Alcoholic Polyneuropathy
7%
Prognostication
7%
Dynamic Modeling
7%
False Negative Result
7%
False Positive Result
7%
DSM-5
7%
Disease
7%
Clinical Trial
6%
Odds Ratio
6%
Neuroscience
Mental Disorder
98%
Natural Language Processing
73%
Cannabis
72%
Psychiatry
57%
Cannabidiol
57%
Meta-Analysis
51%
Mood Disorder
46%
Crossover Study
45%
Tetrahydrocannabinol
43%
Attentional Bias
28%
Substance Abuse
24%
Schizophrenia Spectrum Disorder
20%
Functional Magnetic Resonance Imaging
16%
Antipsychotic
15%
Positive Syndrome
14%
Arterial Spin Labeling
14%
Cognitive Process
14%
Oxytocin
14%
Gray Matter
14%
Negative Syndrome
14%
Precuneus
14%
Intravenous Immunoglobulin
14%
Benzodiazepine
14%
Acetate
14%
Endocannabinoid
14%
Neuroscience
14%
Blood Plasma
14%
Nomogram
14%
Antidepressant
14%
Tobacco Dependence
14%
Comorbidity
14%
Frontal Lobe
13%
Striatum
13%
Anandamide
12%
Hippocampus
9%
Cannabinoid
8%
Disorientation
7%
Thematic Apperception Test
7%
Phencyclidine
7%
Clinical Intervention
7%
Placebo
7%
Longitudinal Study
7%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
45%
Cannabidiol
43%
Cannabis
32%
Syndrome
30%
Prevalence
28%
Schizophrenia Spectrum Disorder
28%
Depressive Disorder
16%
Normal Human
14%
Cohort Study
14%
Mood Disorder
14%
Biomarker Study
14%
Affective Psychosis
14%
Physical Disease
14%
Negative Syndrome
14%
Endocannabinoid
14%
Clinical Study
14%
Methylazoxymethanol Acetate
14%
Randomized Controlled Trial
14%
Dronabinol
14%
Biological Marker
14%
Randomized Clinical Trial
14%
Anandamide
12%
Thrombocyte Activating Factor
9%
Positive Syndrome
9%
All Cause Mortality
9%
Adverse Event
9%
Cannabinoid
8%
Human Study
7%
Disease Severity
7%
SARS Coronavirus
7%
Alzheimer's Disease
7%
Infection Rate
7%
Attention Deficit Disorder
7%
Phencyclidine
7%
Symptomatology
7%
DSM-5
7%
Tetrahydrocannabinol
6%
Benign Childhood Epilepsy
5%
Clinical Trial
5%